reports
- ING Helpdesk
- Jacob Mekhael
Hyloris FIRST LOOK: FY24 results come with a detailed pipeline update
Hyloris reported FY24 results with YE24 cash of € 23.6m (YE23: € 30.4m). Revenue grew to € 8.5m (from € 2.1m), though we note this included one-off milestone payments ($ 2.1m as well as an additional undisclosed amount). We are encouraged by the planned 9 regulatory submissions by YE26, though point out that US filing fees range $ 2-4m. Additionally, Hyloris will require extra funding to commercialise the near-term cardiology products in the US and is exploring multiple options. As such, while w...
- Hilde Van Boxstael
- Jacob Mekhael
- Sharad Kumar S.P
- Thomas Couvreur
- Wim Lewi
- Christophe-Raphaël Ganet
- Konrad Zomer
TKA THYSSENKRUPP AG
MT ARCELORMITTAL SA
JMT JERONIMO MARTINS SGPS S.A.
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
MC LVMH MOET HENNESSY LOUIS VUITTON SE
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
SW SODEXO SA
SZG SALZGITTER AG
EL ESSILORLUXOTTICA SA
WKL WOLTERS KLUWER NV
BRBY BURBERRY GROUP PLC
KER KERING SA
VOE VOESTALPINE AG
ACX ACERINOX SA
RWE RWE AG
AIR AIRBUS SE
VER VERBUND AG CLASS A
ERA ERAMET SA
01913 PRADA S.P.A.
NDA AURUBIS AG
NEM NEMETSCHEK SE
ARCAD ARCADIS NV
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
MONC MONCLER SPA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
HLAG HAPAG-LLOYD AG
RIO RIO TINTO PLC
BHP BHP GROUP LTD
AMAG AMAG AUSTRIA METALL AG
CVC CVC CAPITAL PARTNERS PLC
- ING Helpdesk
Benelux Morning Notes
Arcadis: Further in German rail. CVC Capital Partners: They beat, they score. D'Ieteren: US Belron peer Boyd 4Q24 a bit ahead, weak 2025 early outlook. Fastned: Preview FY24. IBA: 2H24 better REBIT, net cash but outlook on the low side. Proximus: Interim leadership announced. UCB: Peer Immunovant reports mixed results in gMG Zabka: Peer Jeronimo Martins FY24 results
- Jacob Mekhael
Hyloris FIRST LOOK: Positive IDMC recommendation for Alenura phase 2 i...
Hyloris announced that the independent data monitoring committee (IDMC) reviewed the phase 2 trial of Alenura (bladder instillation combining lidocaine and heparin) in interstitial cystitis/bladder pain syndrome (IC/BPS) and concluded that there were no safety concerns and that the efficacy signals observed justified continued investigation. The recommendation is a positive sign for the program particularly as the IDMC saw unblinded data, though we note that they also recommended that the enrolm...
- Kristof Samoy
Arcadis Small add-on acquistion in German rail market
Arcadis acquires WSP Infrastructure Engineering GmbH and strengthens its position in the German rail market. Following the add-on acquisition of the German KUA (data centre design) this is a new small add-on acquisition of €20m turnover company but this time in the Mobility segment. The latter segment was earmarked for acquisitive (bolt-on) growth in earlier comments. Accumulate rating unchanged.
- Hilde Van Boxstael
- Jacob Mekhael
- Thomas Couvreur
- Wim Hoste
- Martijn Den Drijver
IBA reports solid Full Year 2024 results
IBA reports solid Full Year 2024 results Read the entire full year 2024 results press release Louvain-la-Neuve, Belgium, 20 March 2025 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the 2024 financial year. Record-high revenue and return to profitability in 2024 driven by well-executed backlog conversion Net sales rose 7% to €498.2 million1, with Other Accelerators increasing by 18%Gross margin improvement to 33.3% vs. 28.8% in 2023, driven by higher share of Other Accelerators and margin improv...
IBA publie des résultats solides pour l'année 2024
IBA publie des résultats solides pour l'année 2024 pour lire l'intégralité du communiqué de presse des résultats de l'exercice 2024 Louvain-La-Neuve, Belgique, jeudi 20 mars 2025 - IBA (Ion Beam Applications S.A.), le leader mondial de la technologie d’accélération de particules, annonce ce jour ses résultats consolidés pour l’exercice 2024. Chiffre d'affaires record et retour à la rentabilité en 2024 grâce à une conversion efficace du carnet de commandes Chiffre d’affaires en hausse de 7% à 498,2 millions d'euros1, dont une augmentation de 18% pour l’activité Autres AccélérateursA...
Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening it...
Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening its position in the attractive German rail market Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening its position in the attractive German rail market Amsterdam, 20 March 2025 – Arcadis, a global leader in intelligence-driven sustainable design, engineering, and consultancy solutions, has announced the acquisition of WSP Infrastructure Engineering GmbH, a 160-people strong, German based engineering firm specialized in rail infrastructure, signaling, structural engineering and software development. This a...
- ING Helpdesk
- Hilde Van Boxstael
- Jacob Mekhael
- Sharad Kumar S.P
- Thomas Couvreur
- Wim Lewi
- Jacob Mekhael
Hyloris FIRST LOOK: Positive study results for Dofetilide IV, plans FD...
Hyloris announced positive results from a pivotal clinical study evaluating its proprietary Dofetilide IV formulation (potassium channel blocker), an antiarrhythmic to treat atrial fibrillation. Based on company guidance of FDA submission in the coming months, the product could be approved in the US by 2026 taking into account the 10 month FDA review timeline, and we look forward to learn more about the company's US commercialisation plans for its cardiology products. Note that Hyloris has previ...
- ING Helpdesk
Arcadis CFO Virginie Duperat-Vergne to step down on 31 May 2025, Wille...
Arcadis CFO Virginie Duperat-Vergne to step down on 31 May 2025, Willem Baars, current head of Global Strategy, Financing and M&A to assume the role of interim CFO Amsterdam, 5 March 2025 - Arcadis, a global leader in intelligence-driven sustainable design, engineering, and consultancy solutions for natural and built assets, today announced that Virginie Duperat-Vergne has decided to resign as Chief Financial Officer (CFO) and Member of the Executive Board effective from 31 May 2025. Willem Baars will assume the role of interim CFO on 1 June 2025. Willem currently holds the position of Gl...
IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system ...
IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India Louvain-La-Neuve, Belgium, March 04, 2025 – (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a term sheet with Apollo Hospitals Enterprise Limited (AHEL) for the supply of one Proteus®ONE1 compact proton therapy solution plus a second one in option. Apollo will therefore expand access to proton therapy in India. The te...
IBA et Apollo Hospitals signent une lettre d’intention pour l'installa...
IBA et Apollo Hospitals signent une lettre d’intention pour l'installation d’un système Proteus®ONE et d’un second en option en Inde Louvain-la-Neuve, Belgique, le 4 mars 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et le premier fournisseur de solutions de protonthérapie pour le traitement du cancer, annonce aujourd'hui avoir signé une lettre d’intention avec Apollo Hospitals Enterprise Limited (AHEL) pour la fourniture d’une solution de protonthérapie compacte Proteus®ONE1 et d’une seconde en option. Apollo va ainsi é...
IBA Notice of Full Year 2024 Results and Conference Call
IBA Notice of Full Year 2024 Results and Conference Call FY24 results meeting to take place as a hybrid event on Thursday, 20 March 2025 at 2:30pm CET Louvain-la-Neuve, Belgium, 27 February 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the full year 2024 on Thursday, 20 March 2025 at 7am CET. Conference Call Information IBA’s management team will host a hybrid event, including a conference call and webcast conducted in English, to present the full year results, foll...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.